These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 35268759)
1. Ciprofloxacin and Norfloxacin Hybrid Compounds: Potential Anticancer Agents. Peter S; Aderibigbe BA Curr Top Med Chem; 2024; 24(7):644-665. PubMed ID: 38357952 [TBL] [Abstract][Full Text] [Related]
2. Spectroscopic properties (FT-IR, NMR and UV) and DFT studies of amodiaquine. Manwal A Mekoung P; Malloum A; Govindarajan M; Mballa RN; Patouossa I; Abouem A Zintchem A; Nanseu CPN; Mbouombouo IN Heliyon; 2023 Dec; 9(12):e22187. PubMed ID: 38076079 [TBL] [Abstract][Full Text] [Related]
3. Albumin/Thiacalix[4]arene Nanoparticles as Potential Therapeutic Systems: Role of the Macrocycle for Stabilization of Monomeric Protein and Self-Assembly with Ciprofloxacin. Yakimova L; Kunafina A; Mostovaya O; Padnya P; Mukhametzyanov T; Voloshina A; Petrov K; Boldyrev A; Stoikov I Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077448 [TBL] [Abstract][Full Text] [Related]
4. Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones. McDonald M; Blondeau JM J Cataract Refract Surg; 2010 Sep; 36(9):1588-98. PubMed ID: 20692574 [TBL] [Abstract][Full Text] [Related]
5. Fluoroquinolones' Biological Activities against Laboratory Microbes and Cancer Cell Lines. Suaifan GARY; Mohammed AAM; Alkhawaja BA Molecules; 2022 Mar; 27(5):. PubMed ID: 35268759 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety. Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668 [TBL] [Abstract][Full Text] [Related]
7. Detection of antibacterial-like activity on a silica surface: fluoroquinolones and their environmental metabolites. Lewis G; Juhasz A; Smith E Environ Sci Pollut Res Int; 2011 Aug; 19(7):2795-801. PubMed ID: 22311580 [TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolones structural and medicinal developments (2013-2018): Where are we now? Suaifan GARY; Mohammed AAM Bioorg Med Chem; 2019 Jul; 27(14):3005-3060. PubMed ID: 31182257 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility testing: currently used methods and devices and the near future in clinical practice. Benkova M; Soukup O; Marek J J Appl Microbiol; 2020 Oct; 129(4):806-822. PubMed ID: 32418295 [TBL] [Abstract][Full Text] [Related]
13. Organometallic ciprofloxacin conjugates with dual action: synthesis, characterization, and antimicrobial and cytotoxicity studies. Szczupak Ł; Kowalczyk A; Trzybiński D; Woźniak K; Mendoza G; Arruebo M; Steverding D; Stączek P; Kowalski K Dalton Trans; 2020 Feb; 49(5):1403-1415. PubMed ID: 31851200 [TBL] [Abstract][Full Text] [Related]
14. Anticancer and antimicrobial effects of novel ciprofloxacin fatty acids conjugates. Chrzanowska A; Roszkowski P; Bielenica A; Olejarz W; Stępień K; Struga M Eur J Med Chem; 2020 Jan; 185():111810. PubMed ID: 31678743 [TBL] [Abstract][Full Text] [Related]